Salisa Hauptmann
About Salisa Hauptmann
Salisa Hauptmann is a seasoned Chief Regulatory Officer with over 20 years of experience in the biopharmaceutical industry, specializing in global drug development and commercialization.
Salisa Hauptmann's Title and Role
Salisa Hauptmann serves as the Chief Regulatory Officer. In this leadership position, she oversees regulatory strategies, ensuring compliance across diverse biopharmaceutical operations. Her role focuses on maintaining high standards and navigating complex regulatory landscapes.
Salisa Hauptmann's Education and Expertise
Salisa Hauptmann holds a B.A. in History from the University of California, Davis, and a Master's Degree in Public Health Administration from Webster University in St. Louis. Her academic background in public health administration and history complements her extensive expertise in regulatory affairs and biopharmaceutical development.
Salisa Hauptmann's Professional Background
Salisa Hauptmann has a prolific career with over 20 years of experience in the biopharmaceutical industry. She has previously held significant roles at GlaxoSmithKline, Stiefel Laboratories, Novartis, and Merz Pharmaceuticals. These roles have equipped her with in-depth global expertise in drug and biologic commercialization across numerous therapeutic areas.
Salisa Hauptmann's Achievements in Regulatory Affairs
Throughout her career, Salisa Hauptmann has demonstrated extensive regulatory experience in emerging markets. She has led numerous organizational optimization efforts, focusing on operational excellence and process optimization. Additionally, she has successfully implemented Regulatory Operations IT system solutions, ensuring high compliance standards are maintained.